Clinical Trial Update: Capecitabine and Mitomycin C in Treatment of Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating capecitabine in combination with mitomycin C for metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Capecitabine (capecitabine)
• Mitomycin-C (mitomycin C)

Snippet

Sponsor: Croatian Cooperative Group for Clinical Research in Oncology | Conditions: Breast Cancer, Metastasis | Phase 2 | Status: UNKNOWN